Hepatic encephalopathy before and neurological complications after liver transplantation have no impact on the employment status 1 year after transplantation

Table 3 Characteristics of employed and not employed patients after orthotopic liver transplantation

n = 96	Employed (n = 43)	Not employed (n = 53)	P value
Age median (range, min-max)	47 (42, 18-60)	50 (31, 29-60)	0.01
Sex (male/female)	23 (53.5%)/20	36 (67.9%)/17	0.21
Profession Academic/non-academic	13 (31.0%)/29 (NS 1)	8 (15.1%)/45	0.08
labMELD median (range, min-max)	18 (33, 7-40)	19 (33, 7-40)	0.16
Aetiology of liver disease			0.41
PSC	15	13
PBC	1	0
Alcohol	4	8
HCV	7	6
HBV	3	12
AIH	2	1
M. Wilson	2	1
Others	9	12
History of HE (+/-)	13 (30.2%)/30	25 (47.2%)/28	0.10
Neurological complications (+/-)	17 (39.5%)/26	30 (56.6%)/23	0.11
PHES, median (min/max)	0 (-5/+2) (n = 30)	-1 (-10/+4) (n = 43)	0.10
CFF, mean ± SD	45.8 ± 4.0 (n = 29)	42.0 ± 4.1 (n = 40)	< 0.001
RBANS Immediate memory, mean ± SD	101.1 ± 15.1 (n = 30)	92.1 ± 17.7 (n = 41)	0.03
RBANS Visuospatial/constructional, median (range, min-max)	84 (64, 62-126) (n = 30)	89 (57, 64-121) (n = 41)	0.17
RBANS Language, mean ± SD	103.2 ± 13.9 (n = 30)	93.0 ± 16.5 (n = 41)	0.01
RBANS Attention, mean ± SD	101.2 ± 13.7 (n = 30)	89.3 ± 15.5 (n = 41)	0.001
RBANS Delayed memory, median (range, min-max)	98 (109, 10-119) (n = 30)	95 (44, 75-119) (n = 41)	0.13
RBANS Sum score, mean ± SD	490.7 ± 48.2 (n = 30)	461.0 ± 54.5 (n = 41)	0.02
RBANS Total scale, mean ± SD	97.4 ± 13.6 (n = 30)	89.6 ± 14.2 (n = 41)	0.02

P value ≤ 0.05 is considered significant. NS: Not specified; OLT: Orthotopic liver transplantation; labMELD: Laboratory Model of End Stage Liver Disease; PSC: Primary sclerosing cholangitis; PBC: Primary biliary cirrhosis; HCV: Hepatitis C virus; HBV: Hepatitis B virus; AIH: Autoimmune hepatitis; HE: Hepatic encephalopathy; PHES: Psychometric hepatic encephalopathy score; CFF: Critical flicker frequency; RBANS: Repeatable Battery for the Assessment of Neuropsychological Status.